SQZB — SQZ Biotechnologies Co Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $1.18m
- -$9.01m
- $21.48m
Annual cashflow statement for SQZ Biotechnologies Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.3 | -32.2 | -50.5 | -68.7 | -79.5 |
| Depreciation | |||||
| Non-Cash Items | 0.13 | 4.16 | 13.3 | 18.3 | 18.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 39.1 | -6.83 | -7.28 | -32.9 | -24.2 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 21.1 | -33.5 | -43.2 | -82.1 | -83.5 |
| Capital Expenditures | -1.3 | -2.17 | -1.18 | -0.613 | -0.522 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -35.7 | -10.7 | 59 | 0 | 0.034 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -37 | -12.8 | 57.8 | -0.613 | -0.488 |
| Financing Cash Flow Items | 0 | 0 | -1.76 | 54.5 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 68.1 | 26 | 116 | 55.9 | 4.23 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 52.3 | -20.3 | 131 | -26.8 | -79.8 |